The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Integrated analysis of medically treated diabetic patients in the TAXUS® program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments

EuroIntervention 2006;2:61-68 - DOI10.4244/EIJV2I1A11.

1. Southampton University Hospital, Southampton, United Kingdom; 2. Center for Interventional Vascular Therapies, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY, USA; 3. San Raffaele Hospital, Milan, Italy; 4.

Objectives: The TAXUS® database was used to perform an integrated analysis across several large phase II and III trials to assess outcomes of polymer-based paclitaxel-eluting TAXUS s

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.